Skip to content

Advertisement

You're viewing the new version of our site. Please leave us feedback.

Learn more

BMC Cancer

Open Access
Open Peer Review

This article has Open Peer Review reports available.

How does Open Peer Review work?

Nuclear FABP7 immunoreactivity is preferentially expressed in infiltrative glioma and is associated with poor prognosis in EGFR-overexpressing glioblastoma

BMC Cancer20066:97

https://doi.org/10.1186/1471-2407-6-97

Received: 05 November 2005

Accepted: 19 April 2006

Published: 19 April 2006

Back to article

Open Peer Review reports

Pre-publication versions of this article and author comments to reviewers are available by contacting info@biomedcentral.com.

Original Submission
5 Nov 2005 Submitted Original manuscript
1 Dec 2005 Reviewed Reviewer Report - Cathy Nutt
6 Jan 2006 Reviewed Reviewer Report - Paul Mischel
19 Feb 2006 Author responded Author comments - Yu Liang
Resubmission - Version 2
19 Feb 2006 Submitted Manuscript version 2
24 Mar 2006 Reviewed Reviewer Report - Paul Mischel
10 Apr 2006 Reviewed Reviewer Report - Dirk Vordermark
11 Apr 2006 Author responded Author comments - Yu Liang
Resubmission - Version 3
11 Apr 2006 Submitted Manuscript version 3
18 Apr 2006 Author responded Author comments - Yu Liang
Resubmission - Version 4
18 Apr 2006 Submitted Manuscript version 4
Publishing
19 Apr 2006 Editorially accepted
19 Apr 2006 Article published 10.1186/1471-2407-6-97

How does Open Peer Review work?

Open peer review is a system where authors know who the reviewers are, and the reviewers know who the authors are. If the manuscript is accepted, the named reviewer reports are published alongside the article. Pre-publication versions of the article and author comments to reviewers are available by contacting info@biomedcentral.com. All previous versions of the manuscript and all author responses to the reviewers are also available.

You can find further information about the peer review system here.

Authors’ Affiliations

(1)
Department of Neurological Surgery, Brain Tumor Research Center, University of California
(2)
Division of Molecular Biology, Sequence Detection System & Arrays, Applied Biosystems
(3)
Department of Pathology, University of California
(4)
Department of Pathology, Section of Neuropathology, University of Texas M. D. Anderson Cancer Center

Advertisement